Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cancer Biotherapy & Radiopharmaceuticals|January 5, 2023
Reporting Dose in Boron Neutron Capture TherapyWolfgang A G Sauerwein
Cancer Biotherapy & Radiopharmaceuticals|December 28, 2022
Overview of Boron Neutron Capture Therapy in 2022Wolfgang A G Sauerwein, Miha Ulčar
Cancer Biotherapy & Radiopharmaceuticals|April 6, 2023
Strategic Clinical Trial Design for Boron Neutron Capture TherapyAndrea Wittig, Wolfgang A G Sauerwein
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|December 12, 2013
Glioblastoma, brain metastases and soft tissue sarcoma of extremities: candidate tumors for BNCTAndrea Wittig, Raymond L Moss, Wolfgang A G Sauerwein
Medicinal Research Reviews|May 15, 2026
Quantification of 10B and 11B in Biological Samples in Translational Science and Clinical Applications for Boron Neutron Capture Therapy (BNCT)Christoph Selg, Wolfgang A G Sauerwein, Evamarie Hey-Hawkins
Pharmacy World & Science : PWS|July 8, 2005
Boron neutron capture therapy for glioblastoma multiformeCatharina M van Rij, Abraham J Wilhelm, Wolfgang A G Sauerwein, et al.
Radiation Research|September 24, 2009
Biodistribution of (10)B for Boron Neutron Capture Therapy (BNCT) in a mouse model after injection of sodium mercaptoundecahydro-closo-dodecaborate and l-para-boronophenylalanineAndrea Wittig, René Huiskamp, Raymond L Moss, et al.
Molecular Cancer Therapeutics|July 23, 2008
Laser postionization secondary neutral mass spectrometry in tissue: a powerful tool for elemental and molecular imaging in the development of targeted drugsAndrea Wittig, Heinrich F Arlinghaus, Christian Kriegeskotte, et al.
Molecules (Basel, Switzerland)|March 1, 2019
Urinary Proteomics Profiles Are Useful for Detection of Cancer Biomarkers and Changes Induced by Therapeutic ProceduresEmanuele Ferrari, Andrea Wittig, Fabrizio Basilico, et al.
Journal of Cellular and Molecular Medicine|July 16, 2009
EORTC trial 11001: distribution of two 10B-compounds in patients with squamous cell carcinoma of head and neck, a translational research/phase 1 trialAndrea Wittig, Laurence Collette, Klaas Appelman, et al.
Pageof 2